Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-13 · accession 0001610717-23-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-13 | IDYA | Stone Paul A. | CFO | M - OptEx | $4.62 | +8,000 | 21.8K | +58% | +$37.0K |
| D | 2023-04-14 | 2023-04-13 | IDYA | Stone Paul A. | CFO | M - OptEx | $0.00 | -8,000 | 129.8K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-13 | M | A | 8,000 | $4.62 | 21,803 | D | — | — | (F2) The amount reported herein has been adjusted to correct an error in Column 5 of Table I in a Form 4 previously filed on April 14, 2022. |
| 2 | Derivative | Stock Option (right to buy) | 2023-04-13 | M | D | 8,000 | $0.00 | 129,832 | D | $4.62 · — to 2028-06-20 | 8,000 Common Stock | (F1) The shares subject to the option are fully vested and exercisable. |